Bicocca Open Archive

Logo unimib boa
PIPERNO, ALBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.015
EU - Europa 6.180
AS - Asia 2.627
SA - Sud America 67
AF - Africa 14
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 6
Totale 24.916
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.743
CN - Cina 1.152
SE - Svezia 1.048
IE - Irlanda 959
DE - Germania 895
UA - Ucraina 826
SG - Singapore 799
IT - Italia 702
RU - Federazione Russa 663
GB - Regno Unito 367
HK - Hong Kong 358
CA - Canada 264
FI - Finlandia 209
FR - Francia 128
AT - Austria 119
IN - India 81
VN - Vietnam 71
BE - Belgio 62
DK - Danimarca 58
TR - Turchia 52
NL - Olanda 48
BR - Brasile 39
ID - Indonesia 37
BG - Bulgaria 27
JP - Giappone 20
PL - Polonia 13
IR - Iran 12
RO - Romania 11
PE - Perù 9
KR - Corea 8
LT - Lituania 7
TW - Taiwan 7
AR - Argentina 6
CH - Svizzera 6
CZ - Repubblica Ceca 6
EU - Europa 6
EC - Ecuador 5
MY - Malesia 5
PK - Pakistan 5
AU - Australia 4
CL - Cile 4
ES - Italia 4
MX - Messico 4
NO - Norvegia 4
AM - Armenia 3
DO - Repubblica Dominicana 3
GR - Grecia 3
MD - Moldavia 3
PH - Filippine 3
SA - Arabia Saudita 3
SC - Seychelles 3
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
EG - Egitto 2
HR - Croazia 2
HU - Ungheria 2
IL - Israele 2
LK - Sri Lanka 2
MA - Marocco 2
NG - Nigeria 2
NP - Nepal 2
NZ - Nuova Zelanda 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
CI - Costa d'Avorio 1
CO - Colombia 1
DZ - Algeria 1
EE - Estonia 1
KE - Kenya 1
LV - Lettonia 1
MT - Malta 1
OM - Oman 1
PA - Panama 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TN - Tunisia 1
VE - Venezuela 1
ZM - Zambia 1
Totale 24.916
Salva come PNG Salva come JPEG
Città #
Ann Arbor 3.013
Woodbridge 1.748
Fairfield 1.438
Houston 1.327
Chandler 1.026
Dublin 927
Jacksonville 906
Wilmington 746
Ashburn 745
Singapore 665
Frankfurt am Main 623
Seattle 571
Dearborn 565
Cambridge 514
Princeton 361
Hong Kong 352
New York 320
Santa Clara 311
Nanjing 236
Milan 212
Lawrence 174
Shanghai 167
Lachine 155
Altamura 134
Vienna 114
Beijing 105
San Diego 93
Nanchang 74
Andover 67
Shenyang 64
Hebei 54
Brussels 52
Guangzhou 48
Dong Ket 47
Toronto 47
Boardman 45
Helsinki 45
Ottawa 43
Jinan 42
Changsha 40
Jiaxing 38
Jakarta 37
Falls Church 35
Los Angeles 35
Tianjin 33
Zhengzhou 26
Dallas 24
Mountain View 24
Norwalk 24
Fremont 23
London 23
Ningbo 23
Plovdiv 21
Huizen 19
Auburn Hills 16
Hefei 16
Kunming 16
Philadelphia 16
Turin 15
Belo Horizonte 14
Rome 13
Taizhou 13
Munich 12
Pune 12
Hangzhou 11
Kocaeli 11
Lissone 11
Chengdu 10
Verona 10
Detroit 9
Edmonton 9
Phoenix 9
Washington 9
Chicago 8
Chiswick 8
Kilburn 8
Paris 8
Redmond 8
San Francisco 8
San Mateo 8
Segrate 8
University Park 8
Waanrode 8
Fuzhou 7
Monmouth Junction 7
Clarks Summit 6
Kiev 6
Lanzhou 6
Lecco 6
Lima region 6
Loreto 6
Pavia 6
Venezia 6
Bonndorf 5
Cinisello Balsamo 5
Desio 5
Kraków 5
Leawood 5
Meda 5
Nürnberg 5
Totale 19.010
Salva come PNG Salva come JPEG
Nome #
Changes in 24 h ambulatory blood pressure and effects of angiotensin II receptor blockade during acute and prolonged high-altitude exposure: A randomized clinical trial 409
Hepcidin regulation in a mouse model of acute hypoxia 382
Phenotypic heterogeneity in seven Italian cases of aceruloplasminemia 308
GNPAT rs11558492 is not a major modifier of iron status: Study of Italian hemochromatosis patients and blood donors 293
Serum ferritin and liver features in a cohort of 15 patients affected by Gaucher disease 278
A severe hemojuvelin mutation leading to late onset of HFE2-hemochromatosis 256
Juvenile Hemochromatosis 240
Re-evaluation of clinical and histological criteria for diagnosis of dysmetabolic iron overload syndrome 239
Hif1a: A putative modifier of hemochromatosis 217
Hepcidin regulation in a mouse model of acute hypoxia 210
Inherited iron overload disorders 208
Hepcidin and iron-related gene expression in subjects with Dysmetabolic Hepatic Iron Overload 205
Expression of hepcidin and other iron-related genes in type 3 hemochromatosis due to a novel mutation in transferrin receptor-2. 199
Early impairment of large artery structure and function in Type I diabetes mellitus 199
Type 3 hemochromatosis and beta-thalassemia trait 197
Genetic and metabolic factors are associated with increased hepatic iron stores in a selected population of p.Cys282Tyr heterozygotes 196
The presence of two or more metabolic alterations and hepatic steatosis characterizes the dysmetabolic iron overload syndrome 192
Transferrin receptor 2 mutations in patients with juvenile hemochromatosis phenotype 191
Circulating factors are involved in hypoxia-induced hepcidin suppression 190
Immunotherapy with subcutaneous low-dose interleukin-2 and the pineal indole melatonin as a new effective therapy in advanced cancers of the digestive tract 190
Does aceruloplasminemia modulate iron phenotype in thalassemia intermedia? 187
Radial artery wall alterations in genetic hemochromatosis before and after iron depletion therapy 186
Unexplained isolated hyperferritinemia without iron overload 186
Reduced expression of hepcidin in patients with myelodysplastic syndrome and myelofibrosis: the causes might be more heterogeneous than in thalassaemia. 185
Iron Overload Increases Sympathetic Nervous Activity: Study in Hemochromatosis Patients at Diagnosis and Iron Depletion 183
Prolonged exposure to welding fumes as a novel cause of systemic iron overload 178
Hyperferritinemia and diagnosis of type 1 Gaucher disease 177
Novel mutations of the ferroportin gene (SLC40A1): Analysis of 56 consecutive patients with unexplained iron overload 176
Hepatocellular carcinoma in Gaucher disease: an international case series 176
Alterations in sympathetic nerve traffic in genetic haemochromatosis before and after iron depletion therapy: A microneurographic study 173
The iron status of Italian subjects with beta-thalassemia trait 170
HLA typing in 67 Italian patients with idiopathic hemochromatosis and their relatives 170
Hemochromatosis in Italy in the last 30 years: role of genetic and acquired factors 169
CYBRD1 as a modifier gene that modulates iron phenotype in HFE p.C282Y homozygous patients 168
Therapeutic recommendations in HFE hemochromatosis for p.Cys282Tyr (C282Y/C282Y) homozygous genotype 167
Effects of plasma transfusion on hepcidin production in human congenital hypotransferrinemia 165
Patients with chronic hepatitis C may be more sensitive to iron hepatotoxicity than patients with HEF-Hemochromatosis 165
Biochemical and genetic defects underlying human congenital hypotransferrinemia 165
Prevalence of HFE mutations in upper northern Italy: study of 1132 unrelated blood donors 164
Hepcidin response to acute iron intake and chronic iron loading in dysmetabolic iron overload syndrome 164
Heterogeneity of iron overload: Clinical, biochemical, histopathologic and genetic study of 70 patients 164
Dysmetabolic Hepatic Iron Overload Syndrome: Analysis of Hepcidin Response to Acute Oral Iron and Chronic Iron Overload 164
Mental well-being in patients with transfusion-dependent anemias and hemochromatosis during the SARS-CoV-2 pandemic 164
A time course of hepcidin response to oral iron challenge in hfe and tfr2 hemochromatosis patients 164
Hepcidin expression in iron overload diseases is variably modulated by circulating factors 163
Association of hereditary spherocytosis and idiopathic hemochromatosis. A synergistic effect in determining iron overload 163
Serum type III procollagen peptide in alcoholic liver disease and idiopathic hemochromatosis: Its relationship to hepatic fibrosis, activity of the disease and iron overload 163
Homozygous deletion of HFE: The Sardinian hemochromatosis? 160
Measurement of urinary hepcidin levels by SELDI-TOF-MS in HFE-hemochromatosis 160
Proprotein convertase 7 rs236918 associated with liver fibrosis in Italian patients with HFE-related hemochromatosis 159
Ferroportin disease: A novel SLC40A1 mutation 159
Measurement of urinary hepcidin levels by SELDI-TOF-MS in HFE-hemochromatosis 157
S65C frequency in Italian patients with hemochromatosis, porphyria cutanea tarda and chronic viral hepatitis with iron overload 156
Atypical phenotype in a patient with ceruloplasmin mutations in the compound heterozygous state 156
Erythrocyte ferritin in patients on chronic hemodialysis treatment 155
Ceruloplasmin replacement therapy ameliorates neurological symptoms in a preclinical model of aceruloplasminemia 155
Spectrum of hemojuvelin gene mutations in 1q-linked juvenile hemochromatosis 154
Immunohistochemical evaluation of a panel of monoclonal antibodies for the diagnosis of small cell lung cancer 154
Immunohistochemical evidence for a lack of ferritin in duodenal absorptive epithelial cells in idiopathic hemochromatosis 154
Measurement of serum hepcidin-25 levels as a potential test for diagnosing hemochromatosis and related disorders 153
Erythrocyte ferritin in thalassemia syndromes 152
The mitochondrial superoxide dismutase A16V polymorphism in the cardiomyopathy associated with hereditary haemochromatosis 151
Effects of venesections and restricted diet in patients with the Insulin-resistance hepatic iron overload syndrome 150
Angiotensin converting enzyme insertion/deletion polymorphism is related to pressor response to high altitude hypoxia. results of highcare project 150
Hypoadiponectinemia is associated with insulin resistance in patients with non-HFE related hepatic iron overload 149
Increased serum ferritin is common in men with essential hypertension 148
Higher than expected progranulin mutaiton rate in a case series of Ialian FTLD patients 148
Myelodysplastic Syndromes and Iron Chelation Therapy 148
Different cortical excitability profiles in hereditary brain iron and copper accumulation 148
Iron overload in subjects with beta-thalassaemia trait: role of idiopathic haemochromatosis gene 147
Simultaneous liver iron and fat measures by magnetic resonance imaging in patients with hyperferritinemia 147
HFE and SLC40A1 polymorphisms in patients with unexplained iron overload 146
Modulation of hepcidin production during hypoxia-induced erythropoiesis in humans in vivo: data from the HIGHCARE project 145
Idiopathic haemochromatosis and HLA antigens in Italy: is A3 Bw35 HLA haplotype a marker for idiopathic haemochromatosis gene in north east regions? 145
Analysis of Polymorphisms of Genes Regulating Hepcidin Transcription in Hfe-Hemochromatosis 145
IRON AND HYPOXIA LINK: DOWNREGULATION OF LUCIFERASE ACTIVITY OF HEPCIDIN PROMOTER BY HYPOXIC SERA IN HUH-7 CELLS 144
UNEXPLAINED ISOLATED HYPERFERRITINEMIA IN PATIENTS WITHOUT MUTATIONS IN FERRITIN GENE AND L-FERRITIN IRES REGIONS 143
Reduced Insulin Sensitivity is Associated with Adrenergic Overdrive Independently on Obesity and Hypertension 143
Iron chelation therapy in aceruloplasminaemia: study of a patient with a novel missense mutation 143
Factors affecting erythrocyte ferritin content in thalassaemia intermedia 141
Linkage analysis of 6p21 polymorphic markers and the hereditary hemochromatosis: localization of the gene centromeric to HLA-F 141
Modulation of urinary peptidome in humans exposed to high altitude hypoxia 141
Prevalence of C282Y and E168X HFE mutations in an italian population of northern european ancestry 140
Ferritin, metabolic syndrome and NAFLD: Elective attractions and dangerous liaisons 139
Haemochromatosis in patients with β-thalassaemia trait 138
Patatin-like phospholipase domain containing-3 gene I148M polymorphism, steatosis, and liver damage in hereditary hemochromatosis 138
Revisitation of a cohort of 482 Italian patients with hereditary hemochromatosis: Changes in the last three decades 138
The iron-hypoxia link: hepcidin has a central role in the response to acute and chronic exposure to hypobaric hypoxia. data from the highcare project 136
Homozygosity for transferrin receptor-2 y250x mutation induces early iron overload 134
Movement disorders and brain iron overload in a new subtype of aceruloplasminemia 134
Iron accumulation in chronic hepatitis C: relation of hepatic iron distribution, HFE genotype, and disease course 133
Screening hepcidin for mutations in juvenile hemochromatosis: identification of a new mutation (c70r) 133
Saturability of hepatic iron deposits in genetic hemochromatosis 133
Natural history of juvenile haemochromatosis 132
Oxidative stress and antioxidant defence mechanisms in response to chronic hypobaric hypoxia. Results of the HIGHCARE project 132
Novel human pathological mutations. Gene symbol: ALPL. Disease: hypophosphatasia. 131
Index measured at an intermediate altitude to predict impending acute mountain sickness 131
High prevalence of the His63Asp HFE mutation in Italian patients with porphyria cutanea tarda 131
Liver iron concentration in chronic viral hepatitis: a study of 98 patients 130
Time course of circulatory and humoral effects of rapid total paracentesis in cirrhotic patients with tense, refractory ascites 129
Totale 17.077
Salva come PNG Salva come JPEG
Categoria #
all - tutte 86.191
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 86.191
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.635 0 0 0 0 0 558 682 358 465 202 295 75
2020/20212.953 233 129 338 327 244 200 265 190 252 361 179 235
2021/20222.444 110 261 325 231 181 135 115 137 110 160 196 483
2022/20233.871 552 1.107 344 344 226 583 26 233 250 22 115 69
2023/20242.611 100 95 97 71 341 614 565 162 193 48 53 272
2024/20252.269 396 675 231 241 565 161 0 0 0 0 0 0
Totale 25.684